Efficacy and Safety of Pioglitazone Monotherapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

Pioglitazone, the only thiazolidinedione drug in clinical practice is under scrutiny due to reported adverse effects, it’s unique insulin sensitising action provides rationale to remain as a therapeutic option for managing type 2 diabetes mellitus (T2DM). We conducted a systematic review and meta-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Fahmida, Islam, Md. Asiful, Mohamed, Mafauzy, Ahmad, Imran, Kamal, Mohammad Amjad, Donnelly, Richard, Idris, Iskandar, Gan, Siew Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441028/
https://www.ncbi.nlm.nih.gov/pubmed/30926892
http://dx.doi.org/10.1038/s41598-019-41854-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441028/
https://www.ncbi.nlm.nih.gov/pubmed/30926892
http://dx.doi.org/10.1038/s41598-019-41854-2

Ejemplares similares